CASTRATE RESISTANT PROSTATE CANCER
Clinical trials for CASTRATE RESISTANT PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new CASTRATE RESISTANT PROSTATE CANCER trials appear
Sign up with your email to follow new studies for CASTRATE RESISTANT PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Prostate cancer study cancelled before it started
Disease control TerminatedThis study aimed to see if a person's race or ethnicity changed how well a drug combination (niraparib, abiraterone acetate, and prednisone) worked for a certain type of advanced prostate cancer. It planned to enroll Black, Hispanic, White, and Native American men whose cancer ha…
Matched conditions: CASTRATE RESISTANT PROSTATE CANCER
Phase: PHASE2 • Sponsor: Latin American Cooperative Oncology Group • Aim: Disease control
Last updated May 26, 2026 03:19 UTC
-
New radiation therapy aims to control Hard-to-Treat prostate cancer
Disease control ENROLLING_BY_INVITATIONThis study tests a new treatment called 177Lu-HTK03170 for men with a type of advanced prostate cancer that has stopped responding to hormone therapy. The treatment delivers radiation directly to cancer cells using a targeting molecule. The goal is to find a safe dose and see if …
Matched conditions: CASTRATE RESISTANT PROSTATE CANCER
Phase: PHASE1, PHASE2 • Sponsor: British Columbia Cancer Agency • Aim: Disease control
Last updated May 12, 2026 13:42 UTC
-
Which prostate cancer drug is kinder to your brain?
Knowledge-focused OngoingThis study looks at how two different prostate cancer medications, darolutamide and enzalutamide, affect thinking skills like memory and attention. About 111 men with advanced prostate cancer will take one of the two drugs and complete computer-based brain tests over time. The go…
Matched conditions: CASTRATE RESISTANT PROSTATE CANCER
Phase: PHASE2 • Sponsor: Alliance Foundation Trials, LLC. • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC